One In The Eye For Hexo From The Pen Of Motley Fool, “1 Cannabis Stock to Avoid At All Costs”

One In The Eye For Hexo From The Pen Of Motley Fool, “1 Cannabis Stock to Avoid At All Costs”

Here’s teh introduction to the piece. Cannabis company HEXO (NYSE: HEXO) has several things going its way. For instance, the pot grower teamed up with alcoholic beverage maker Molson Coors (NYSE: TAP) in 2018, and out of this partnership was born a joint venture, dubbed Truss Beverages. HEXO is looking to make a dent in the potentially lucrative cannabis derivative market in Canada via this joint venture. Through its acquisition of Newstrike Brands for 263 million Canadian dollars (about $201 million) in March 2019, HEXO was able to increase its production capacity. With a projected peak output of about 150,000 kilograms per year, HEXO now ranks in the top 10 pot growers in Canada by production capacity. Furthermore, HEXO holds the leading market share in the adult-use cannabis market in Quebec, which is the second-largest Canadian province by population. Despite these advantages, HEXO — which saw its shares plunge by 53.6% last year — shouldn’t be on the list of cannabis stocks you want to buy. Here’s why.   HEXO’s share dilution Over the past few years, many of the top pot companies have raised significant amounts of capital through dilutive forms of financing, including issuing such securities as stock and convertible debentures. On the one hand, dilution can sometimes be a…

Excerpt only …
READ MORE BELOW
Source : CANNANNEW REPORT
Link to original : One In The Eye For Hexo From The Pen Of Motley Fool, “1 Cannabis Stock to Avoid At All Costs”
reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.